Horizon Discovery in Cambridge UK has bought additional CRISPR IP from the Broad Institute of MIT. Dr Darrin Disley, Entrepreneur in Residence at the Centre for Entrepreneurial Learning and CEO at Horizon Discovery Group plc, said ‘the technology has the potential to revolutionise functional genomics.’
Read the full article [businessweekly.co.uk]
Comments